International Journal of Radiation Oncology * Biology * Physics
Volume 80, Issue 4 , Pages 1008-1014 , 15 July 2011

Impact of [18F]Fluorodeoxyglucose PET-CT Staging on Treatment Planning in Radiotherapy Incorporating Elective Nodal Irradiation for Non-Small-Cell Lung Cancer: A Prospective Study

  • Milena Kolodziejczyk, M.D.

      Affiliations

    • Department of Radiation Oncology, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    • ,
  • Lucyna Kepka, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    • Corresponding Author InformationReprint requests to: Lucyna Kepka, M.D., Ph.D., Department of Radiation Oncology, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, ul. Roentgena 5, 02-776 Warsaw, Poland. Tel: 48 22 5462076; Fax: 48 22 6439287
    • ,
  • Miroslaw Dziuk, M.D., Ph.D.

      Affiliations

    • Mazovian PET-CT Center, Military Institute of Health Services, Warsaw, Poland
    • ,
  • Anna Zawadzka

      Affiliations

    • Department of Medical Physics, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    • ,
  • Norbert Szalus, M.D.

      Affiliations

    • Mazovian PET-CT Center, Military Institute of Health Services, Warsaw, Poland
    • ,
  • Agnieszka Gizewska, M.D.

      Affiliations

    • Mazovian PET-CT Center, Military Institute of Health Services, Warsaw, Poland
    • ,
  • Krzysztof Bujko, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

Received 20 December 2009 ,Revised 23 March 2010 ,Accepted 1 April 2010.

References 

  1. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer. Chest. 2007;132:178S–201S
  2. MacManus M, Nestle U, Rosenzweig KE, et al. Use of PET and PET-CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol. 2009;91:85–94
  3. Kiffer JD, Berlangieri SU, Scott AM, et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer. 1998;19:167–177
  4. Munley MT, Marks LB, Scarfone C, et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer. 1999;23:105–114
  5. Nestle U, Walter K, Schmidt S, et al. 18F-deoxyglucose positron emission tomography (FDG-PET) fort he planning of radiotherapy in lung cancer: High impact in patients with atelectasis. Int J Radiat Oncol Biol Phys. 1999;44:593–597
  6. Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, et al. The impact of (18)F-fluoro-2-deoxy-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol. 2000;55:317–324
  7. MacManus MP, Hicks RJ, Ball DL, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer. 2001;92:886–895
  8. Giraud P, Grahek D, Montravers F, et al. CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys. 2001;49:1249–1257
  9. Mah K, Caldwell CB, Ung YC, et al. The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study. Int J Radiat Oncol Biol Phys. 2002;52:339–350
  10. Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol. 2002;62:51–60
  11. Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:78–86
  12. Deniaud-Alexandre E, Touboul E, Lerouge D, et al. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005;63:1432–1441
  13. Ashamalla H, Rafla S, Parikh K, et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys. 2005;63:1016–1023
  14. Van Der Wel A, Nijsten S, Hochstenbag M, et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2–N3M0 non-small-cell lung cancer: A modeling study. Int J Radiat Oncol Biol Phys. 2005;61:649–655
  15. Nohl-Oser HC. An investigation of the anatomy of the lymphatic drainage of the lungs as shown by the lymphatic spread of bronchial carcinoma. 1972;51:157–176.
  16. Kelsey CR, Light KL, Marks LB. Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys. 2006;65:1097–1105
  17. Kepka L, Bujko K, Zolciak-Siwinska A, et al. Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer. Acta Oncol. 2008;47:954–961
  18. Kepka L, Bujko K, Zolciak-Siwinska A. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques. Acta Oncol. 2008;47:95–103
  19. Rosenzweig KE, Sim SE, Mychalczak B, et al. Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2001;50:681–685
  20. Videtic GM, Rice TW, Murthy S, et al. Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: Insights for radiotherapy planning from a surgical cohort. Int J Radiat Oncol Biol Phys. 2008;72:702–706
  21. Belderbos JSA, Kepka L, Kong F-M (Spring), et al. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: Non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2008;72:335–342
  22. Yuan S, Sun X, Li M, et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol. 2007;30:239–244
  23. Kepka L, Tyc-Szczepaniak D, Bujko K. Dose-per-fraction escalation of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer. J Thorac Oncol. 2009;4:853–861
  24. Chapet O, Kong F-M, Quint LE, et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys. 2005;63:170–178
  25. Kepka L, Bujko K, Garmol D, et al. Delineation variation of lymph node stations for treatment planning in lung cancer radiotherapy. Radiother Oncol. 2007;85:450–455
  26. Schild SE. Elective Nodal Irradiation (ENI) doesn't appear to provide a clear benefit for patients with unresectable non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2008;72:311–312
  27. Kelsey CR, Marks LB, Glatstein E. Elective nodal irradiation for locally advanced non-small-cell lung cancer: it's called cancer for a reason. Int J Radiat Oncol Biol Phys. 2009;73:1291–1292
  28. Kepka L, Maciejewski B, Withers HR. Does incidental irradiation with doses lower than 50 Gy effectively reduce isolated nodal recurrences in non-small-cell lung cancer: dose-response relationship. Int J Radiat Oncol Biol Phys. 2009;73:1391–1396
  29. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg. 2007;32:1–8
  30. Hoyer ER, Leonard CR, Hazuka MB, et al. Medistinoscopy incisional metastasis. A radiotherapeutic approach. Cancer. 1992;70:1612–1615
  31. Rintoul RC, Tournoy KG, El Daly H, et al. EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience. J Thorac Oncol. 2009;4:44–48

 Conflict of interest: none.

PII: S0360-3016(10)00591-2

doi: 10.1016/j.ijrobp.2010.04.018

International Journal of Radiation Oncology * Biology * Physics
Volume 80, Issue 4 , Pages 1008-1014 , 15 July 2011

Article Tools